Accepting PhD Students

PhD projects

<a href="" onclick="target='_blank';"></a>


Research activity per year

If you made any changes in Pure these will be visible here soon.

Personal profile


Associate Professor Zanfina Ademi joined the Faculty of Pharmacy and Pharmaceutical Sciences in February 2022 as a Lead Health Economist within the Centre for Medicine Use and Safety. She leads a program of research around prevention of cardiovascular disease, population genomics, epilepsy management and other chronic health conditions. She also leads a program of research on the Productivity Adjusted Life Years (PALYs), which aim to quantify productivity loss at population level and incorporate productivity explicitly in decision making. 

She specialises in Health Technology Assessments (HTAs), economic evaluations alongside clinical trials and clinical registries and decision health economic modelling. She has worked in Australia, Finland and Switzerland, leading funded research projects that have provided evidence on cost-effectiveness and return on investment enabling key decision-makers (governments, payers) to enact effective healthcare funding across the world.

She supervises medical/pharmacy research projects and PhD students. Her collaborations include Monash University (School of Public Health/Central Clinical School), Florey Institute, University of Sydney, University of Western Australia and Curtin University. She also leads an external collaboration with Cambridge University.

Currently, she serves in a number of reputable national and international committees with translational impact, such as the Economics Sub-Committee (ESC) of Australia’s Pharmaceutical Benefits Advisory Committee (PBAC). 

Previously, Zanfina held a leading position at Monash Outcomes Research and Health Economics (MORE) and was Deputy Director of the Centre of Cardiovascular Research and Education in Therapeutics (CCRET) in the School of Public Health and Preventive Medicine. 

She has authored >150 peer-reviewed publications, including in the top-ranking journals European Heart Journal, BMJ, New England Journal of Medicine, Lancet, Stroke, Diabetes Care, Hypertension, Value in Health, and PharmacoEconomics. She has also contributed to a book on the Encyclopedia of Pharmacy Practice and Clinical Pharmacy - Economic evaluation of pharmaceuticals.

She is passionate about teaching and coordinates several units across Monash.

Expertise related to UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):

  • SDG 3 - Good Health and Well-being

Education/Academic qualification

Health Economics, Epidemiology, PhD, MONASH UNIVERSITY

Award Date: 7 Jun 2011

Public Health, Epidemiology , MPH, Ita-Suomen Yliopisto (University of Eastern Finland)

Award Date: 20 Dec 2006

Pharmacy, MPharm, University of Medicine of Tirana

Award Date: 30 Jun 2003

External positions

Member - Pharmaceutical Benefits Advisory Committee, Economics Sub-committee, Department of Health and Aged Care (Australia)

1 Jan 2022 → …

Honorary Fellow, Florey Institute of Neuroscience and Mental Health (FINMH) (Victoria)

2021 → …

Convener for the Special Interest Group: Economics of Genomics and Precision Medicine, International Health Economics Association (iHEA)

2021 → …

Editorial Board Member PharmacoEconomics

2020 → …

Associate Editor, International Journal of Technology Assessment in Health Care

2020 → …

Faculty Advisor for the Victorian and Tasmanian Student Chapter, International Society of Pharmacoeconomics and Outcomes Research (ISPOR)

2020 → …

Senior Research Scientist , Universität Basel (University of Basel)

Jun 2014Feb 2018

Research Fellow , University of Melbourne

Mar 2011Jun 2014

Research area keywords

  • Economic Evaluation
  • Epidemiology
  • Health Service Research
  • Cardiovascular Research
  • Chronic Disease modelling
  • Neuroscience
  • Healthy Living
  • Quality Of Life
  • Productivity
  • Outcomes Research
  • Health Technology Assessments
  • Cost Effectiveness
  • Budget Impact Analysis
  • Cost of Illness
  • Prediction Analysis
  • Clinical Trials
  • Clinical registries
  • Mendelian Randomization analyses


Recent external collaboration on country/territory level. Dive into details by clicking on the dots or